The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 22, 2011

Filed:

Oct. 25, 2007
Applicants:

John K. Sullivan, Newbury Park, CA (US);

Joseph G. Mcgivern, Oak Park, CA (US);

Leslie P. Miranda, Thousand Oaks, CA (US);

Hung Q. Nguyen, Thousand Oaks, CA (US);

Kenneth W. Walker, Newbury Park, CA (US);

Shaw-fen Sylvia HU, Thousand Oaks, CA (US);

Colin V. Gegg, Jr., Newbury Park, CA (US);

Taruna Arora Khare, Thousand Oaks, CA (US);

Beverly S. Adler, Newbury Park, CA (US);

Francis H. Martin, Newbury Park, CA (US);

Inventors:

John K. Sullivan, Newbury Park, CA (US);

Joseph G. McGivern, Oak Park, CA (US);

Leslie P. Miranda, Thousand Oaks, CA (US);

Hung Q. Nguyen, Thousand Oaks, CA (US);

Kenneth W. Walker, Newbury Park, CA (US);

Shaw-Fen Sylvia Hu, Thousand Oaks, CA (US);

Colin V. Gegg, Jr., Newbury Park, CA (US);

Taruna Arora Khare, Thousand Oaks, CA (US);

Beverly S. Adler, Newbury Park, CA (US);

Francis H. Martin, Newbury Park, CA (US);

Assignee:

Amgen Inc., Thousand Oaks, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/16 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.


Find Patent Forward Citations

Loading…